PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

‘Defund the Police’ Movement Could Mean More Lone Wolf Attacks: Terrorism Experts

Show Me

Baked Alaska Says FBI Is Trying To Force Him To Become An Informant With Threats Of Federal Prison Time Over 1/6

Show Me

Medicaid Enrollment Surpassed 80 Million, a Record, During the Pandemic

Show Me

June 21, 2021 | Nightly News Rebroadcast | Video: 49 Minutes 47 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded June 21, 2021 | Video: 48 Minutes 32 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded June 21, 2021 | Video: 48 Minutes 43 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded June 21, 2021 | Video: 48 Minutes 56 Seconds

Show Me

Bannon’s War Room | Saturday Edition Hour 1 | Recorded June 19, 2021 | Video: 48 Minutes 45 Seconds

Show Me

Bannon’s War Room | Saturday Edition Hour 2 | Recorded June 19, 2021 | Video: 48 Minutes 47 Seconds

Show Me

June 18, 2021 | Nightly News Rebroadcast | Video: 53 Minutes 48 Seconds

Show Me

California Introduces COVID-19 Vaccine Verification System

Show Me

Smith & Wesson CEO Says Ammo Shortage Won’t End Soon: ‘Still a Lot of Interest’

Show Me

Unvaccinated West Point cadets getting bullied and punished, families say

Show Me

Thousands gather at Download to enjoy bands with mosh pits, no social distancing and no masks

Show Me

Why Shutdowns and Masks Suit the Elite

Show Me

Juneteenth is now a federal holiday. Many Americans still get the history wrong

Show Me

Sidney Powell summoned to Detroit for sanctions hearing

Show Me

Dozens Of Women Sue Pornhub After It Allegedly Posted Non-Consensual Sex Videos

Show Me

Georgia Election Audit Info Increasingly Troubling

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded June 18, 2021 | Video: 48 Minutes 50 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded June 18, 2021 | Video: 48 Minutes 30 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded June 18, 2021 | Video: 48 Minutes 58 Seconds

Show Me

June 17, 2021 | Nightly News Rebroadcast | Video: 53 Minutes 06 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded June 17, 2021 | Video: 48 Minutes 17 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded June 17, 2021 | Video: 48 Minutes 28 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded June 17, 2021 | Video: 48 Minutes 58 Seconds

Show Me

The Real Story – OAN Missing Election Ballots with Garland Favorito | Video: 10 Minutes 57 Seconds

Show Me

Dr. Kelli Ward, Arizona GOP Chairwoman gives the latest on America’s Audit | Video: 8 Minutes

Show Me

Anti-Police Movement Strikes Portland | Video: 2 Minutes 8 Seconds

Show Me

Powell Exposes Corrupt Federal Prosecutors And How They Target Innocent People With Fake Crimes | Video: 4 Minutes 45 Seconds

Show Me

Soy Boy Reporter Tries To Attack Mike Lindell And Gets Owned

Show Me

EU Approves COVID Passport: Here’s How It Works — and Why the U.S. Doesn’t Have One

Show Me

26 people hit by gunfire in Chicago Tuesday — including 8 in a house in Englewood and 5 on the street in West Garfield Park

Show Me

Peter Andre apologises for promoting swimming with dolphins in YouTube video – after PETA letter

Show Me

Lyft Driver Charged For Allegedly Sexually Assaulting Teen Passenger

Show Me

What Does It Mean to Be Crowned ‘Miss Juneteenth’?

Show Me

Thousands call for Jeff Bezos to be denied re-entry to Earth after space launch

Show Me

Afghanistan: Deliberate killing of civilians must be investigated following deadly attacks

Show Me

Army Long Range Strike Gives China a Taste of Its Own Medicine

Show Me

DeSantis: ‘We Are Not Allowing Discrimination Based on Vaccination Status’

Show Me